Advertisement

Topics

Vyome Biosciences Completes Enrollment for Proof of Concept Clinical Study of VB 1953 in Patients with Moderate to Severe Acne

14:00 EDT 24 Apr 2017 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced it completed enrollment in its proof-of-concept stud...

Other Sources for this Article

For Vyome Biosciences
Nic DiBella, +1-617-657-1307
nic@jpa.com

NEXT ARTICLE

More From BioPortfolio on "Vyome Biosciences Completes Enrollment for Proof of Concept Clinical Study of VB 1953 in Patients with Moderate to Severe Acne"

Quick Search
Advertisement
 

Relevant Topics

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...

Acne
Acne is a common skin condition that causes spots to develop on the skin, usually on the face, back and chest..  The spots can range from blackheads and whiteheads which are often mild, to inflamed pus-filled pustules and cysts, which can be severe ...